Drug Trial Radar · NCT06609239
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
900
Planned (sponsor's estimate)
Start
Sep 30, 2024
Primary completion
Jan 20, 2031
Study completion Jan 20, 2031
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Sep 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have previously completed the parent studies. After completion of the parent study, eligible participants will be offered the opportunity to participate in the long-term extension (LTE) study with lunsekimig. The study duration will be up to 148 weeks with a treatment duration being up to 144 weeks.
Conditions
- Asthma
Interventions
LunsekimigDrug
* Pharmaceutical form: Solution for injection in vial or pre-filled syringe (PFS) * Route of administration: Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Exposure-adjusted incidence rate of treatment-emergent adverse event (TEAE), including adverse events of special interest (AESI), and serious adverse event (SAE)Time frame: From study baseline to week 148
Locations
150 sites in 21 countries. Site status is shown where the registry gives one.
Chandler Clinical Research Trials- Site Number : 8400075
Chandler, Arizona
Tucson Clinical Research Institute- Site Number : 8400085
Tucson, Arizona
Allianz Research Institute - Aurora- Site Number : 8400026
Aurora, Colorado
Western States Clinical Research- Site Number : 8400014
Wheat Ridge, Colorado
Helix Biomedics- Site Number : 8400114
Boynton Beach, Florida
Beautiful Minds Clinical Research Center- Site Number : 8400049
Cutler Bay, Florida
Qway Research - Hialeah- Site Number : 8400015
Hialeah, Florida
Ilumina Medical Research- Site Number : 8400095
Kissimmee, Florida
Clintex Research Group - Miami - Southwest 27th Avenue- Site Number : 8400048
Miami, Florida
High Quality Research- Site Number : 8400039
Miami, Florida
Innovations Biotech- Site Number : 8400040
Miami, Florida
New Access Medical Center- Site Number : 8400043
Miami, Florida
Deluxe Health Center- Site Number : 8400045
Miami Lakes, Florida
Tellabio International Research Services- Site Number : 8400083
Pembroke Pines, Florida
Alfa Medical Research LLC- Site Number : 8400146
Pembroke Pines, Florida
Avanza Medical Research Center- Site Number : 8400135
Pensacola, Florida
Windom Allergy, Asthma and Sinus Specialists- Site Number : 8400019
Sarasota, Florida
Private Practice - Dr. David Kavtaradze- Site Number : 8400081
Cordele, Georgia
Brigham & Women's Hospital- Site Number : 8400034
Boston, Massachusetts
University of Michigan Health System - Ann Arbor- Site Number : 8400004
Ann Arbor, Michigan
Midwest Clinical Research Center - St. Louis- Site Number : 8400006
St Louis, Missouri
Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400029
Charlotte, North Carolina
Asthma & Allergy Center - Toledo- Site Number : 8400017
Toledo, Ohio
OK Clinical Research- Site Number : 8400021
Edmond, Oklahoma
Clinical Research Associates of Central Pennsylvania- Site Number : 8400116
DuBois, Pennsylvania
Allergy & Clinical Immunology Associates Pittsburgh- Site Number : 8400007
Pittsburgh, Pennsylvania
Orion Clinical Research- Site Number : 8400001
Austin, Texas
South Texas Medical Research Institute - TTS Research- Site Number : 8400010
Boerne, Texas
Baylor University Medical Center- Site Number : 8400002
Dallas, Texas
Western Sky Medical Research- Site Number : 8400023
El Paso, Texas
Metroplex Pulmonary and Sleep Center- Site Number : 8400022
McKinney, Texas
Investigational Site Number : 0320005
Buenos Aires, Argentina
Investigational Site Number : 0320012
Buenos Aires, Argentina
Investigational Site Number : 0320004
Buenos Aires, Argentina
Investigational Site Number : 0320011
Buenos Aires, Argentina
Investigational Site Number : 0320009
Mendoza, Argentina
Investigational Site Number : 0320015
Mendoza, Argentina
Investigational Site Number : 0320010
Santa Fe, Argentina
Investigational Site Number : 0320007
Berazategui, Buenos Aires, Argentina
Investigational Site Number : 0320003
La Plata, Buenos Aires, Buenos Aires, Argentina
Showing 40 of 150 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.